Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oblin

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2001
The preclinical pharmacologic profile of tiaprideB Scatton, C Cohen, G Perrault, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityH Schoemaker, Y Claustre, D Fage, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptorsG Griebel, G Perrault, J Simiand, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Psychiatry : the Journal of the Association of European Psychiatrists|August 25, 2001
The preclinical pharmacologic profile of tiaprideB Scatton, C Cohen, G Perrault, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1997
Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivityH Schoemaker, Y Claustre, D Fage, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptorsG Griebel, G Perrault, J Simiand, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2003
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessationC Cohen, O E Bergis, F Galli, et al.
Pageof 3